As I now understand Rexin-G is now approved for first indication use in Japan for breast cancer. The Mayo Clinic is finishing stage 3 trials with very positive results.
If anyone would like more info e-mail
--- Message edited by CancerCompass staff: for personal protection, email address removed. Please review CancerCompass Member Guidelines at http://www.cancercompass.com/common/guidelines.html ---- . God Bless.